Frazier Financial Advisors, LLC Genmab A/S Transaction History
Frazier Financial Advisors, LLC
- $129 Billion
- Q3 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Genmab A/S stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 465 shares of GMAB stock, worth $10,448. This represents 0.01% of its overall portfolio holdings.
Number of Shares
465
Previous 465
-0.0%
Holding current value
$10,448
Previous $11.7 Million
2.99%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GMAB
# of Institutions
238Shares Held
49MCall Options Held
6.8KPut Options Held
27.6K-
Alliancebernstein L.P. New York, NY15.2MShares$342 Million0.14% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$114 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.23MShares$95 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.77MShares$62.2 Million0.4% of portfolio
-
Wellington Management Group LLP Boston, MA2.31MShares$51.8 Million0.01% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14.8B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...